Matisse Capital’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,333
| Closed | -$468K | – | 187 |
|
|
2024
Q1 | $468K | Buy |
34,333
+24,333
| +243% | +$332K | 0.23% | 126 |
|
|
2023
Q4 | $135K | Buy |
+10,000
| New | +$135K | 0.07% | 191 |
|
|
2021
Q3 | – | Sell |
-165,000
| Closed | -$3.54M | – | 159 |
|
|
2021
Q2 | $3.54M | Sell |
165,000
-154,311
| -48% | -$3.31M | 1.12% | 29 |
|
|
2021
Q1 | $6.29M | Hold |
319,311
| – | – | 1.81% | 12 |
|
|
2020
Q4 | $6.31M | Hold |
319,311
| – | – | 1.96% | 10 |
|
|
2020
Q3 | $5.61M | Sell |
319,311
-2,957
| -0.9% | -$52K | 2.25% | 8 |
|
|
2020
Q2 | $5.79M | Buy |
322,268
+128,237
| +66% | +$2.3M | 1.92% | 12 |
|
|
2020
Q1 | $2.91M | Buy |
+194,031
| New | +$2.91M | 1.14% | 33 |
|